US Stock MarketDetailed Quotes

Tango Therapeutics (TNGX)

Watchlist
  • 20.560
  • -4.310-17.33%
Close May 15 16:00 ET
  • 20.730
  • +0.170+0.83%
Post 19:58 ET
2.97BMarket Cap-24.77P/E (TTM)

Tango Therapeutics (TNGX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.39%-44.36M
-5.62%-138.89M
18.91%-29.72M
7.30%-30.95M
-54.70%-36.52M
-10.14%-41.7M
-11.46%-131.5M
-33.42%-36.65M
-7.24%-33.39M
3.54%-23.61M
Net income from continuing operations
-14.14%-45.51M
22.03%-101.59M
-2.86%-38.75M
154.46%15.88M
-52.06%-38.85M
-5.17%-39.88M
-28.07%-130.3M
-22.45%-37.67M
-31.01%-29.17M
-23.38%-25.55M
Depreciation and amortization
-25.56%463K
-8.72%2.28M
-22.74%479K
-10.77%555K
-1.11%625K
-0.48%622K
3.48%2.5M
0.49%620K
1.47%622K
4.64%632K
Other non cash items
3.87%993K
3.08%3.88M
-0.53%939K
3.29%972K
5.06%1.02M
4.48%956K
3.86%3.77M
3.28%944K
0.86%941K
7.56%968K
Change In working capital
0.41%-9.98M
-111.68%-67.2M
133.59%2.4M
-362.12%-54.43M
13.92%-5.16M
-46.63%-10.02M
16.38%-31.75M
-852.93%-7.15M
26.47%-11.78M
37.03%-5.99M
-Change in receivables
----
--0
----
----
----
----
--0
--0
--0
--0
-Change in prepaid assets
-454.24%-2.3M
-576.49%-1.76M
139.37%350K
-33.33%-1.65M
-151.92%-1.11M
80.28%649K
116.63%370K
-165.51%-889K
-10.63%-1.24M
566.04%2.14M
-Change in payables and accrued expense
-53.65%-6.91M
658.00%279K
420.57%3.26M
-1.49%1.26M
0.79%256K
-692.59%-4.49M
98.66%-50K
-125.99%-1.02M
134.22%1.28M
-79.61%254K
-Change in other current assets
900.00%10K
-795.35%-299K
-244.44%-13K
1,100.00%20K
-30,800.00%-307K
-97.14%1K
204.88%43K
800.00%9K
94.29%-2K
-83.33%1K
-Change in other current liabilities
-0.13%-781K
-41.68%-3.03M
-5.20%-1.19M
-16.67%-245K
-33.88%-814K
-314.89%-780K
12.26%-2.14M
-93.52%-1.13M
46.43%-210K
59.11%-608K
-Change in other working capital
----
-108.16%-62.38M
--0
-363.65%-53.81M
59.09%-3.18M
16.67%-5.39M
4.94%-29.97M
24.19%-4.12M
-8.14%-11.61M
18.99%-7.78M
Cash from discontinued investing activities
Operating cash flow
-6.39%-44.36M
-5.62%-138.89M
18.91%-29.72M
7.30%-30.95M
-54.70%-36.52M
-10.14%-41.7M
-11.46%-131.5M
-33.42%-36.65M
-7.24%-33.39M
3.54%-23.61M
Investing cash flow
Cash flow from continuing investing activities
-68.51%9.64M
-147.45%-40.87M
-360.69%-135.72M
45.77%47.48M
32.12%16.78M
373.11%30.6M
107.90%86.13M
53.79%52.06M
157.48%32.57M
-61.15%12.7M
Net PPE purchase and sale
103.92%2K
-38.99%-1.05M
-79.03%-222K
-31.30%-151K
-95.00%-624K
73.85%-51K
50.59%-754K
45.13%-124K
-618.75%-115K
51.81%-320K
Net investment purchase and sale
-68.57%9.63M
-145.83%-39.82M
-359.65%-135.5M
45.72%47.63M
33.67%17.4M
378.42%30.65M
102.27%86.88M
53.13%52.18M
157.70%32.69M
-60.96%13.02M
Cash from discontinued investing activities
Investing cash flow
-68.51%9.64M
-147.45%-40.87M
-360.69%-135.72M
45.77%47.48M
32.12%16.78M
373.11%30.6M
107.90%86.13M
53.79%52.06M
157.48%32.57M
-61.15%12.7M
Financing cash flow
Cash flow from continuing financing activities
3,992,200.00%79.85M
366.81%222.5M
22,539.42%219.38M
5.79%2.54M
-55.68%581K
-100.00%2K
-42.16%47.66M
-33.95%969K
-97.01%2.4M
123.72%1.31M
Net common stock issuance
--62.78M
409.07%212.4M
--212.4M
--0
--0
--0
-47.86%41.72M
--0
--0
--0
Proceeds from stock option exercised by employees
880,150.00%17.61M
70.61%10.14M
623.63%7.01M
5.79%2.54M
-55.68%581K
-99.84%2K
206.08%5.94M
15.22%969K
444.67%2.4M
123.72%1.31M
Net other financing activities
---537K
---36K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
3,992,200.00%79.85M
366.81%222.5M
22,539.42%219.38M
5.79%2.54M
-55.68%581K
-100.00%2K
-42.16%47.66M
-33.95%969K
-97.01%2.4M
123.72%1.31M
Net cash flow
Beginning cash position
59.29%114.85M
3.28%72.1M
9.32%60.91M
-22.71%41.84M
-4.29%61M
3.28%72.1M
9.15%69.81M
-10.07%55.72M
-22.08%54.13M
5.04%63.73M
Current changes in cash
506.57%45.12M
1,767.58%42.75M
229.27%53.94M
1,105.18%19.07M
-99.65%-19.16M
-82.59%-11.1M
-60.87%2.29M
108.63%16.38M
121.04%1.58M
-209.06%-9.6M
End cash Position
162.25%159.97M
59.29%114.85M
59.29%114.85M
9.32%60.91M
-22.71%41.84M
-4.29%61M
3.28%72.1M
3.28%72.1M
-10.07%55.72M
-22.08%54.13M
Free cash flow
-6.26%-44.36M
-5.81%-139.93M
18.58%-29.94M
7.17%-31.1M
-55.23%-37.14M
-9.71%-41.75M
-10.67%-132.26M
-32.78%-36.77M
-7.56%-33.51M
4.81%-23.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.39%-44.36M-5.62%-138.89M18.91%-29.72M7.30%-30.95M-54.70%-36.52M-10.14%-41.7M-11.46%-131.5M-33.42%-36.65M-7.24%-33.39M3.54%-23.61M
Net income from continuing operations -14.14%-45.51M22.03%-101.59M-2.86%-38.75M154.46%15.88M-52.06%-38.85M-5.17%-39.88M-28.07%-130.3M-22.45%-37.67M-31.01%-29.17M-23.38%-25.55M
Depreciation and amortization -25.56%463K-8.72%2.28M-22.74%479K-10.77%555K-1.11%625K-0.48%622K3.48%2.5M0.49%620K1.47%622K4.64%632K
Other non cash items 3.87%993K3.08%3.88M-0.53%939K3.29%972K5.06%1.02M4.48%956K3.86%3.77M3.28%944K0.86%941K7.56%968K
Change In working capital 0.41%-9.98M-111.68%-67.2M133.59%2.4M-362.12%-54.43M13.92%-5.16M-46.63%-10.02M16.38%-31.75M-852.93%-7.15M26.47%-11.78M37.03%-5.99M
-Change in receivables ------0------------------0--0--0--0
-Change in prepaid assets -454.24%-2.3M-576.49%-1.76M139.37%350K-33.33%-1.65M-151.92%-1.11M80.28%649K116.63%370K-165.51%-889K-10.63%-1.24M566.04%2.14M
-Change in payables and accrued expense -53.65%-6.91M658.00%279K420.57%3.26M-1.49%1.26M0.79%256K-692.59%-4.49M98.66%-50K-125.99%-1.02M134.22%1.28M-79.61%254K
-Change in other current assets 900.00%10K-795.35%-299K-244.44%-13K1,100.00%20K-30,800.00%-307K-97.14%1K204.88%43K800.00%9K94.29%-2K-83.33%1K
-Change in other current liabilities -0.13%-781K-41.68%-3.03M-5.20%-1.19M-16.67%-245K-33.88%-814K-314.89%-780K12.26%-2.14M-93.52%-1.13M46.43%-210K59.11%-608K
-Change in other working capital -----108.16%-62.38M--0-363.65%-53.81M59.09%-3.18M16.67%-5.39M4.94%-29.97M24.19%-4.12M-8.14%-11.61M18.99%-7.78M
Cash from discontinued investing activities
Operating cash flow -6.39%-44.36M-5.62%-138.89M18.91%-29.72M7.30%-30.95M-54.70%-36.52M-10.14%-41.7M-11.46%-131.5M-33.42%-36.65M-7.24%-33.39M3.54%-23.61M
Investing cash flow
Cash flow from continuing investing activities -68.51%9.64M-147.45%-40.87M-360.69%-135.72M45.77%47.48M32.12%16.78M373.11%30.6M107.90%86.13M53.79%52.06M157.48%32.57M-61.15%12.7M
Net PPE purchase and sale 103.92%2K-38.99%-1.05M-79.03%-222K-31.30%-151K-95.00%-624K73.85%-51K50.59%-754K45.13%-124K-618.75%-115K51.81%-320K
Net investment purchase and sale -68.57%9.63M-145.83%-39.82M-359.65%-135.5M45.72%47.63M33.67%17.4M378.42%30.65M102.27%86.88M53.13%52.18M157.70%32.69M-60.96%13.02M
Cash from discontinued investing activities
Investing cash flow -68.51%9.64M-147.45%-40.87M-360.69%-135.72M45.77%47.48M32.12%16.78M373.11%30.6M107.90%86.13M53.79%52.06M157.48%32.57M-61.15%12.7M
Financing cash flow
Cash flow from continuing financing activities 3,992,200.00%79.85M366.81%222.5M22,539.42%219.38M5.79%2.54M-55.68%581K-100.00%2K-42.16%47.66M-33.95%969K-97.01%2.4M123.72%1.31M
Net common stock issuance --62.78M409.07%212.4M--212.4M--0--0--0-47.86%41.72M--0--0--0
Proceeds from stock option exercised by employees 880,150.00%17.61M70.61%10.14M623.63%7.01M5.79%2.54M-55.68%581K-99.84%2K206.08%5.94M15.22%969K444.67%2.4M123.72%1.31M
Net other financing activities ---537K---36K--------------------------------
Cash from discontinued financing activities
Financing cash flow 3,992,200.00%79.85M366.81%222.5M22,539.42%219.38M5.79%2.54M-55.68%581K-100.00%2K-42.16%47.66M-33.95%969K-97.01%2.4M123.72%1.31M
Net cash flow
Beginning cash position 59.29%114.85M3.28%72.1M9.32%60.91M-22.71%41.84M-4.29%61M3.28%72.1M9.15%69.81M-10.07%55.72M-22.08%54.13M5.04%63.73M
Current changes in cash 506.57%45.12M1,767.58%42.75M229.27%53.94M1,105.18%19.07M-99.65%-19.16M-82.59%-11.1M-60.87%2.29M108.63%16.38M121.04%1.58M-209.06%-9.6M
End cash Position 162.25%159.97M59.29%114.85M59.29%114.85M9.32%60.91M-22.71%41.84M-4.29%61M3.28%72.1M3.28%72.1M-10.07%55.72M-22.08%54.13M
Free cash flow -6.26%-44.36M-5.81%-139.93M18.58%-29.94M7.17%-31.1M-55.23%-37.14M-9.71%-41.75M-10.67%-132.26M-32.78%-36.77M-7.56%-33.51M4.81%-23.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More